GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (FRA:BUWA) » Definitions » Cyclically Adjusted PS Ratio

Bio-Rad Laboratories (FRA:BUWA) Cyclically Adjusted PS Ratio : 2.93 (As of Jun. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Bio-Rad Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-06-08), Bio-Rad Laboratories's current share price is €263.10. Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €89.90. Bio-Rad Laboratories's Cyclically Adjusted PS Ratio for today is 2.93.

The historical rank and industry rank for Bio-Rad Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:BUWA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.59   Med: 3.48   Max: 9.77
Current: 2.98

During the past years, Bio-Rad Laboratories's highest Cyclically Adjusted PS Ratio was 9.77. The lowest was 1.59. And the median was 3.48.

FRA:BUWA's Cyclically Adjusted PS Ratio is ranked worse than
59.12% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs FRA:BUWA: 2.98

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was €19.692. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €89.90 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bio-Rad Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Cyclically Adjusted PS Ratio Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.71 7.29 8.74 4.56 3.41

Bio-Rad Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.11 4.00 3.76 3.41 3.59

Competitive Comparison of Bio-Rad Laboratories's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted PS Ratio falls into.



Bio-Rad Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bio-Rad Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=263.10/89.9
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bio-Rad Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=19.692/131.7762*131.7762
=19.692

Current CPI (Mar. 2024) = 131.7762.

Bio-Rad Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 13.581 100.560 17.797
201409 14.131 100.428 18.542
201412 16.592 99.070 22.070
201503 14.916 99.621 19.730
201506 15.348 100.684 20.088
201509 14.224 100.392 18.671
201512 17.743 99.792 23.430
201603 14.341 100.470 18.810
201606 15.544 101.688 20.143
201609 15.277 101.861 19.764
201612 18.174 101.863 23.511
201703 15.631 102.862 20.025
201706 14.969 103.349 19.086
201709 14.912 104.136 18.870
201712 17.410 104.011 22.057
201803 14.825 105.290 18.554
201806 16.314 106.317 20.221
201809 15.423 106.507 19.082
201812 17.948 105.998 22.313
201903 16.286 107.251 20.010
201906 16.806 108.070 20.493
201909 17.065 108.329 20.759
201912 18.554 108.420 22.551
202003 17.133 108.902 20.732
202006 15.861 108.767 19.216
202009 18.240 109.815 21.888
202012 21.478 109.897 25.754
202103 20.225 111.754 23.848
202106 19.710 114.631 22.658
202109 21.010 115.734 23.922
202112 21.430 117.630 24.007
202203 21.236 121.301 23.070
202206 21.943 125.017 23.129
202209 23.126 125.227 24.336
202212 23.225 125.222 24.441
202303 21.252 127.348 21.991
202306 21.416 128.729 21.923
202309 20.268 129.860 20.567
202312 21.697 129.419 22.092
202403 19.692 131.776 19.692

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bio-Rad Laboratories  (FRA:BUWA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bio-Rad Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (FRA:BUWA) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (FRA:BUWA) Headlines

No Headlines